Cleared Traditional

K051071 - VIRAMED BIOTECH BORRELIA B31 IGG VIRABLOT (FDA 510(k) Clearance)

Aug 2005
Decision
107d
Days
Class 2
Risk

K051071 is an FDA 510(k) clearance for the VIRAMED BIOTECH BORRELIA B31 IGG VIRABLOT. This device is classified as a Reagent, Borrelia Serological Reagent (Class II - Special Controls, product code LSR).

Submitted by Viramed Biotech AG (Oceanside, US). The FDA issued a Cleared decision on August 11, 2005, 107 days after receiving the submission on April 26, 2005.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3830.

Submission Details

510(k) Number K051071 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 2005
Decision Date August 11, 2005
Days to Decision 107 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code LSR - Reagent, Borrelia Serological Reagent
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3830